Lv5
1276 积分 2024-10-31 加入
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors
11天前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
11天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
11天前
已完结
AP-1: a double-edged sword in tumorigenesis
12天前
已完结
Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours
16天前
已完结
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors
16天前
已完结
The evolving landscape of CDK2 inhibition in cancer: Therapeutic potential, clinical progress, and future directions
1个月前
已完结
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies
1个月前
已完结
NK Cells and Polymorphonuclear Neutrophils Are Both Critical for IL-2-Induced Pulmonary Vascular Leak Syndrome
1个月前
已完结
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer
3个月前
已完结
皖公网安备34019202002308
